Similarly, aptamers against cancer biomarkers, such as carcinoembryonic antigen (CEA), MCF-7 breast cancer cells, and prostate specific antigen (PSA) were developed to realize reliable and timely cancer diagnosis (Wang et al., 2015; Yang et al., 2015; Zhang et al., 2015). This evidence concerns the gene KLK3 and breast carcinoma.